The Flare of Rheumatic Disease After SARS-CoV-2 Vaccination: A Review

As the coronavirus disease 2019 (COVID-19) pandemic continues worldwide, vaccination has been considered an effective measure to protect people from the COVID-19 and end the pandemic. However, for patients with rheumatic diseases (RD), concern for the induction of RD flare may combat the enthusiasm...

Full description

Bibliographic Details
Main Authors: Yan Xie, Yang Liu, Yi Liu
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-07-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2022.919979/full
_version_ 1811323836376809472
author Yan Xie
Yang Liu
Yi Liu
author_facet Yan Xie
Yang Liu
Yi Liu
author_sort Yan Xie
collection DOAJ
description As the coronavirus disease 2019 (COVID-19) pandemic continues worldwide, vaccination has been considered an effective measure to protect people from the COVID-19 and end the pandemic. However, for patients with rheumatic diseases (RD), concern for the induction of RD flare may combat the enthusiasm for vaccination. In general, current evidence doesn’t support the increased risk of disease flare after COVID-19 vaccination. However, the disease flare of RDs may be triggered by COVID-19 vaccinations, especially for patients with high disease activity. Most of these flares after vaccination are mild and need no treatment escalation. Considering the benefits and risks, RD patients are recommended to receive the COVID-19 vaccination but should be vaccinated when the RDs are in stable states.
first_indexed 2024-04-13T14:03:26Z
format Article
id doaj.art-869d070b176d4219a86ef4b5afcf638e
institution Directory Open Access Journal
issn 1664-3224
language English
last_indexed 2024-04-13T14:03:26Z
publishDate 2022-07-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj.art-869d070b176d4219a86ef4b5afcf638e2022-12-22T02:44:00ZengFrontiers Media S.A.Frontiers in Immunology1664-32242022-07-011310.3389/fimmu.2022.919979919979The Flare of Rheumatic Disease After SARS-CoV-2 Vaccination: A ReviewYan Xie0Yang Liu1Yi Liu2Department of Rheumatology and Immunology, West China Hospital, Sichuan University, Chengdu, ChinaTsinghua Clinical Research Institute (TCRI), School of Medicine, Tsinghua University, Beijing, ChinaDepartment of Rheumatology and Immunology, West China Hospital, Sichuan University, Chengdu, ChinaAs the coronavirus disease 2019 (COVID-19) pandemic continues worldwide, vaccination has been considered an effective measure to protect people from the COVID-19 and end the pandemic. However, for patients with rheumatic diseases (RD), concern for the induction of RD flare may combat the enthusiasm for vaccination. In general, current evidence doesn’t support the increased risk of disease flare after COVID-19 vaccination. However, the disease flare of RDs may be triggered by COVID-19 vaccinations, especially for patients with high disease activity. Most of these flares after vaccination are mild and need no treatment escalation. Considering the benefits and risks, RD patients are recommended to receive the COVID-19 vaccination but should be vaccinated when the RDs are in stable states.https://www.frontiersin.org/articles/10.3389/fimmu.2022.919979/fullCOVID-19SARS-CoV-2vaccinerheumatic diseaseflare
spellingShingle Yan Xie
Yang Liu
Yi Liu
The Flare of Rheumatic Disease After SARS-CoV-2 Vaccination: A Review
Frontiers in Immunology
COVID-19
SARS-CoV-2
vaccine
rheumatic disease
flare
title The Flare of Rheumatic Disease After SARS-CoV-2 Vaccination: A Review
title_full The Flare of Rheumatic Disease After SARS-CoV-2 Vaccination: A Review
title_fullStr The Flare of Rheumatic Disease After SARS-CoV-2 Vaccination: A Review
title_full_unstemmed The Flare of Rheumatic Disease After SARS-CoV-2 Vaccination: A Review
title_short The Flare of Rheumatic Disease After SARS-CoV-2 Vaccination: A Review
title_sort flare of rheumatic disease after sars cov 2 vaccination a review
topic COVID-19
SARS-CoV-2
vaccine
rheumatic disease
flare
url https://www.frontiersin.org/articles/10.3389/fimmu.2022.919979/full
work_keys_str_mv AT yanxie theflareofrheumaticdiseaseaftersarscov2vaccinationareview
AT yangliu theflareofrheumaticdiseaseaftersarscov2vaccinationareview
AT yiliu theflareofrheumaticdiseaseaftersarscov2vaccinationareview
AT yanxie flareofrheumaticdiseaseaftersarscov2vaccinationareview
AT yangliu flareofrheumaticdiseaseaftersarscov2vaccinationareview
AT yiliu flareofrheumaticdiseaseaftersarscov2vaccinationareview